SCHEMBL21929286

SCHEMBL21929286

Cc1cccc(-c2ccc3c(c2)c2cc(-c4cccc(C)c4)ccc2n3-c2cncc(-n3c4ccc(-c5cccc(C)c5)cc4c4cc(-c5cccc(C)c5)ccc43)c2-c2ccc(C#N)cc2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 4/20 0.46
CYP11B1 P15538 3/20 0.46
MAPK14 Q16539 1/20 0.41
CHEK1 O14757 1/20 0.37
AR P10275 3/20 0.36
SIRT2 Q8IXJ6 2/20 0.36
KDM1A O60341 1/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
HPGD P15428 1/20 0.36
TSHR P16473 1/20 0.36
MAPK1 P28482 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HSD17B10 Q99714 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
PTGER4 P35408 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21929266 0.96 CYP11B2 (0.43) CYP11B2CYP11B1MAPK14CHEK1AR
SCHEMBL21928407 0.93 CYP1A2 (0.42) CYP11B2CYP11B1MAPK14KDM4EALDH1A1
SCHEMBL21929285 0.91 CYP11B2 (0.46) CYP11B2CYP11B1MAPK14CHEK1AR
SCHEMBL21928450 0.91 SCN10A (0.39) CYP11B2CYP11B1CHEK1ARKDM1A
SCHEMBL21928432 0.89 MAP4K4 (0.41) CYP11B2CYP11B1ALDH1A1CYP1A2CYP17A1
SCHEMBL21928614 0.89 MAPKAPK2 (0.42) CYP11B2CYP11B1CHEK1ARKDM1A
SCHEMBL26776900 0.89 CYP11B1 (0.40) CYP11B2CYP11B1MAPK14CHEK1AR
SCHEMBL24737209 0.89 AR (0.40) CYP11B2CYP11B1CHEK1ARKDM1A
SCHEMBL21929271 0.89 CYP11B2 (0.43) CYP11B2CYP11B1MAPK14CHEK1AR
SCHEMBL24737204 0.89 CYP1A2 (0.40) CYP11B2CYP11B1KDM4EALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220388960-A1 ORGANIC MOLECULES FOR USE IN LIGHT-EMITTING DEVICES CYNORA GMBH (DE) 2022-12-08 US disclosed
US-20200136054-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2020-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200136054-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, OGFR, OR51E2 CYP11B2 902/4885CYP11B1 1431/4885MAPK14 3308/4885
US-20220388960-A1 ORGANIC MOLECULES FOR USE IN LIGHT-EMITTING DEVICES ALDH1A2, AOX1, CYBA CYP11B2 163/4885CYP11B1 432/4885MAPK14 3830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.